Drug Profile


Alternative Names: 5PU; 882C; 882C87; BW 882; Py-araU; Zonavir

Latest Information Update: 15 Jul 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antivirals; Nucleosides; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Varicella zoster virus infections

Most Recent Events

  • 15 Jul 1998 In vitro data has been added to the antimicrobial activity section .
  • 21 Aug 1996 A study has been added to the therapeutic trials section
  • 29 May 1995 A comparison of aciclovir and netivudine has been added to the therapeutic trials section .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top